BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND AFF1, MLLT2, 4299, ENSG00000172493, P51825, AF-4, PBM1 AND Treatment
6 results:

  • 1. Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
    Conter V; Valsecchi MG; Cario G; Zimmermann M; Attarbaschi A; Stary J; Niggli F; Dalla Pozza L; Elitzur S; Silvestri D; Locatelli F; Möricke A; Engstler G; Smisek P; Bodmer N; Barbaric D; Izraeli S; Rizzari C; Boos J; Buldini B; Zucchetti M; von Stackelberg A; Matteo C; Lehrnbecher T; Lanvers-Kaminsky C; Cazzaniga G; Gruhn B; Biondi A; Schrappe M
    J Clin Oncol; 2024 Mar; 42(8):915-926. PubMed ID: 38096462
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements.
    Wen J; Zhou M; Shen Y; Long Y; Guo Y; Song L; Xiao J
    BMC Cancer; 2022 Aug; 22(1):859. PubMed ID: 35933338
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ameloblastic fibrosarcoma: clinicopathological and molecular analysis of seven cases highlighting frequent BRAF and occasional NRAS mutations.
    Agaimy A; Skalova A; Franchi A; Alshagroud R; Gill AJ; Stoehr R; Baumhoer D; Bauer S
    Histopathology; 2020 May; 76(6):814-821. PubMed ID: 31899815
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A revised definition for cure of childhood acute lymphoblastic leukemia.
    Pui CH; Pei D; Campana D; Cheng C; Sandlund JT; Bowman WP; Hudson MM; Ribeiro RC; Raimondi SC; Jeha S; Howard SC; Bhojwani D; Inaba H; Rubnitz JE; Metzger ML; Gruber TA; Coustan-Smith E; Downing JR; Leung WH; Relling MV; Evans WE
    Leukemia; 2014 Dec; 28(12):2336-43. PubMed ID: 24781017
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A translocation in acute lymphoblastic leukemia that cytogenetically mimics the recurrent MLL-aff1 translocation and fuses SEPT11 to MLL.
    Stevens SJ; Meers LE; Albrechts JC; Mebis-Verhees K; Bos GM; Engelen JJ; Janssen JW
    Cancer Genet Cytogenet; 2010 Aug; 201(1):48-51. PubMed ID: 20633769
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.